This year’s Business of Biotech (BOB) 2015 will focus on the quantitative concepts underlying private and venture investment in life sciences, including therapeutics and medical devices. This is a three-evening seminar from May 18-May 20 from
4:30pm-6:30pm in Hope room 216 (333 Cedar St, School of Medicine) followed by a daily networking provided dinner. After the Wednesday class please join the organizers and speakers for a dinner and drinks provided networking event at Archie Moore’s.
This years BOB will be followed by YEI’s biotech bootcamp on May 21, so you can asses your newly acquired Biotech concepts.
All from the BioHaven community are welcome.
To register please click [https://www.eventbrite.com/e/yale-business-of-biotechnology-seminar-series-2015-tickets-15861933470].
During the first hour (M-W), Constance McKee MBA SOM 1986 will present basic quantitative and financial concepts. During the second hour, guest speakers will present micro-case studies of decisions in the life sciences industry. Joining us will be:
·M: Alan Carr PhD, Senior Analyst, Biotechnology, Needham & Co (confirmed)
· T: Kathryn Smith, consultant to Progressive MS Alliance, National Multiple Sclerosis Society; ex-Pfizer (confirmed)
· W: Christopher Loose, PhD, Executive Director, Center for Biomedical and Interventional Technology (CBIT) (confirmed)
· W: Konstantine Drakonakis PhD, Director, Launch Capital (New Haven, New York, Palo Alto) (invited)
Dinner will be provided for all talks.